Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications?
Joshua W. Miller
*
, Andre Smith
,
Aron M. Troen
, Joel B. Mason
, Paul F. Jacques
, Jacob Selhub
*
Corresponding author for this work
Institute of Biochemistry, Food Science and Nutrition
Research output
:
Contribution to journal
›
Article
›
peer-review
31
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Folic Acid
100%
Vitamin B12 Deficiency
100%
High Dose
50%
Folic Acid Supplements
37%
Folate
25%
Pernicious Anemia
25%
Older Adults
12%
Epilepsy
12%
Neuropathology
12%
Malabsorption
12%
Folic Acid Fortification
12%
Clinical Evidence
12%
Serum B12
12%
Treatment Strategy
12%
Acid Concentration
12%
Clinical Observation
12%
Epidemiological Evidence
12%
Plasma Homocysteine
12%
Folic Acid Supplementation
12%
Holotranscobalamin
12%
Megaloblastic Anemia
12%
Cognitive Function Test
12%
Methylmalonic Acid
12%
Medicine and Dentistry
Folic Acid
100%
Vitamin B12 Deficiency
100%
Cyanocobalamin
91%
Drug Megadose
33%
Pernicious Anemia
16%
Homocysteine
8%
Malabsorption
8%
Supplementation
8%
Clinical Observation
8%
Masking
8%
Epilepsy
8%
Cognitive Function Test
8%
Methylmalonic Acid
8%
Megaloblastic Anemia
8%
Alertness
8%
Biochemistry, Genetics and Molecular Biology
Folic Acid
100%
Vitamin B12 Deficiency
100%
Cyanocobalamin
91%
Deficiency
50%
Drug Megadose
33%
Homocysteine
8%
Masking
8%
Cognition
8%
Alertness
8%
Pharmacology, Toxicology and Pharmaceutical Science
Folic Acid
100%
Cyanocobalamin Deficiency
100%
Vitamin B12
91%
Pernicious Anemia
16%
Malabsorption
8%
Epilepsy
8%
Homocysteine
8%
Megaloblastic Anemia
8%
Methylmalonic Acid
8%